Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Extemporaneous compounding in veterinary practice: a New Zealand perspective.

Gargiulo DA, Chemal C, Joda L, Lee YJ, Pilkington M, Haywood A, Garg S.

N Z Vet J. 2013 Nov;61(6):311-5. doi: 10.1080/00480169.2013.773853. Epub 2013 Apr 2.

PMID:
23544952
2.

Compounding for animal patients: contemporary issues.

Lust E.

J Am Pharm Assoc (2003). 2004 May-Jun;44(3):375-84; quiz 384-6. Review.

PMID:
15191248
3.

Veterinary compounding in small animals: a clinical pharmacologist's perspective.

Boothe DM.

Vet Clin North Am Small Anim Pract. 2006 Sep;36(5):1129-73, viii. Review.

PMID:
16984830
4.

Comparison of prescribing and dispensing processes between veterinarians and pharmacists in New Zealand: Are there opportunities for cooperation?

McDowell A, Assink L, Musgrave R, Soper H, Williams C, Norris P.

Pharm Pract (Granada). 2011 Jan;9(1):23-30. Epub 2011 Mar 15.

5.

FDA/CVM's Compliance Policy Guide on compounding of drugs.

[No authors listed]

J Am Vet Med Assoc. 1996 Dec 15;209(12):2025-9.

PMID:
8960175
6.

Drug compounding for veterinary patients.

Papich MG.

AAPS J. 2005 Sep 22;7(2):E281-7. Review.

7.

Extemporaneous compounding activities and the associated informational needs of pharmacists.

Crawford SY, Dombrowski SR.

Am J Hosp Pharm. 1991 Jun;48(6):1205-10.

PMID:
1858798
8.

Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.

Kairuz T, Chhim S, Hasan F, Kumar K, Lal A, Patel R, Singh R, Dogra M, Garg S.

N Z Med J. 2007 Mar 23;120(1251):U2466.

PMID:
17384694
9.

Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.

Buurma H, de Smet PA, van den Hoff OP, Sysling H, Storimans M, Egberts AC.

Pharm World Sci. 2003 Dec;25(6):280-7.

PMID:
14689817
10.

Attitudes towards perception and management of pain in rabbits and guinea pigs by a sample of veterinarians in New Zealand.

Keown AJ, Farnworth MJ, Adams NJ.

N Z Vet J. 2011 Nov;59(6):305-10. doi: 10.1080/00480169.2011.609477.

PMID:
22040336
11.

Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.

Zaid AN, Al-Ramahi R, Shahed Q, Saleh B, Elaraj J.

Int J Pharm Pract. 2012 Feb;20(1):9-14. doi: 10.1111/j.2042-7174.2011.00157.x. Epub 2011 Aug 19.

PMID:
22236175
12.

Characterizing specialized compounding in community pharmacies.

Giam JA, McLachlan AJ, Krass I.

Res Social Adm Pharm. 2012 May-Jun;8(3):240-52. doi: 10.1016/j.sapharm.2011.05.003. Epub 2011 Aug 6.

PMID:
21824824
14.

Potential risks of pharmacy compounding.

Gudeman J, Jozwiakowski M, Chollet J, Randell M.

Drugs R D. 2013 Mar;13(1):1-8. doi: 10.1007/s40268-013-0005-9. Review.

15.

Practices of pharmacies that compound extemporaneous formulations.

Treadway AK, Craddock D, Leff R.

Am J Health Syst Pharm. 2007 Jul 1;64(13):1403-9.

PMID:
17592006
16.

Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.

Lam MS.

Pharmacotherapy. 2011 Feb;31(2):164-92. doi: 10.1592/phco.31.2.164. Review.

PMID:
21275495
17.

Rationale for compounding commercially available products.

Murry T.

Am J Vet Res. 2009 Nov;70(11):1307; author reply 1307-8. doi: 10.2460/ajvr.70.11.1307. No abstract available.

PMID:
19878010
18.

Policies for the vaccination of cats and dogs in New Zealand veterinary practices.

Cave NJ, Jackson R, Bridges JP.

N Z Vet J. 2016 May;64(3):145-53. doi: 10.1080/00480169.2015.1114434. Epub 2015 Nov 29.

PMID:
26553450
19.

Descriptive epidemiological study of the use of antimicrobial drugs by companion animal veterinarians in New Zealand.

Pleydell EJ, Souphavanh K, Hill KE, French NP, Prattley DJ.

N Z Vet J. 2012 Mar;60(2):115-22. doi: 10.1080/00480169.2011.643733.

PMID:
22352928
20.
Items per page

Supplemental Content

Write to the Help Desk